Comparison Of The Effect Of Final Rinse Of Tramadol and Dexamethasone on Post-Endodontic Pain in Teeth With SIP
The Comparison Of The Effect Of Intracanal Rinse of Tramadol and Dexamethasone on Post-Endodontic Pain in Teeth With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial
1 other identifier
interventional
105
1 country
1
Brief Summary
Briefly, 105 teeth with symptomatic irreversible pulpitis will be included in the study and randomly allocated to three groups (A, B and C). Pre-Operative pain score using VAS will be taken after which root canal treatment shall be initiated. Group A (35 teeth) will receive normal saline as a final irrigant. 35 teeth each of Groups B and C will receive Dexamethasone and Tramadol Solutions, respectively as final irrigants. Post-operative pain scores will be recorded after 6, 12, 24 and 48 hours after the procedure. Statistical analysis will be performed using SPSS version 26.0. Mean comparison of pre-treatment and post-treatment VAS scores will be done by repeated measure two-way ANOVA. Post-hoc LSD test will be applied for pairwise comparison within and/or between groups. The sample size of 105 subjects (35 including 5 as a drop out per group) is calculated using PASS version 15, based on two sample proportion with 95% confidence of interval and 80% power of test, no pain in dexamethasone (81.7%) and drug2
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2025
CompletedFirst Submitted
Initial submission to the registry
May 15, 2025
CompletedFirst Posted
Study publicly available on registry
June 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 17, 2025
CompletedJune 25, 2025
June 1, 2025
9 months
May 15, 2025
June 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-Operative Pain intensity
Measurement Tool : Visual Analogue Scale (VAS) Unit Of Measure : Pain intensity will be assessed on a 0-10 scale, where 0 represents no pain and 10 represents the worst pain imaginable.
6 to 48 hours
Study Arms (3)
Tramadol Group
EXPERIMENTALGroup A 30 participants will receive Tramadol as part of root canal treatment.
dexamethasone group
EXPERIMENTALDexamehasone as a final irrigant
Normal Saline group
PLACEBO COMPARATORnormal saline as a final irrigant
Interventions
Drug used as final irrigant
drug used as a final irrigant
Eligibility Criteria
You may qualify if:
- ASA 1 and ASA 2 eligible patients
- Patients aged between 18 and 50 years
- Mandibular Single rooted teeth diagnosed with symptomatic irreversible pulpitis
- Preoperative pain measured with the help of visual analogue scale and
You may not qualify if:
- Patients who have taken any analgesic at least 12 hours before the procedure
- Teeth diagnosed with pulpal necrosis and periradicular periodontitis
- Teeth non restorable due to any reason,
- Root canal calcifications and resorptions.
- Women with breast feeding and pregnancy
- Patients allergic to any of the two drugs shall also be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
DIOKHS,Dow University Of Health Sciences
Karachi, Sindh, KARACHI WEST, Pakistan
Study Officials
- STUDY CHAIR
Muhammad AM Amin, FCPS
Dow University of Health Sciences
- STUDY DIRECTOR
Fazal FM Qazi, FCPS
Dow University of Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Patients included in the study will pick an envelope A, B or C for inclusion in the Group A, B or C. Researcher will himself be responsible for randomization and recruitment of participants into groups. In this Double blinded study neither clinician or patient will not know the drug of the envelope and the syringes will be masked by white paper labeled A, B and C by the dental assistant.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MDS Trainee Of Operative Dentistry, Dow University Of Health Sciences
Study Record Dates
First Submitted
May 15, 2025
First Posted
June 25, 2025
Study Start
March 4, 2025
Primary Completion
November 17, 2025
Study Completion
November 17, 2025
Last Updated
June 25, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 2to3years
- Access Criteria
- Journal
Study will be published in a recongnized Journal to share with other researchers